Page 19 - SPEMD_60-4

rev port estomatol med dent cir maxilofac . 2019;60(4):163-168 167

for HSV-1, CMV and EBV, no samples were positive for HSV-1 Conflict of interest
and CMV and three presented DNA amplification for EBV.
These results highlight the literature statements that EBV oc- The authors have no conflicts of interest to declare.
27
curs later in life in developed countries, but mainly during
childhood in developing countries. 28 references
For more precise results, real-time PCR, as well as more ad-
vanced technologies, could aid in detecting those viruses more 1. Stanulla M, Schrappe M. Treatment of Childhood Acute
Lymphoblastic Leukemia. Semin Hematol. 2009;46:52-63.
accurately, because some may remain in a latent state of the 2. Silverman LB, Stevenson KE, O’Brien JE, Asselin BL, Barr RD,
infection with low levels of viral genic expression, being barely Clavell L, et al. Long-term results of Dana-Farber Cancer
detectable. Despite the limitation of access to molecular biol- Institute ALL Consortium protocols for children with newly
19
ogy techniques, more studies need to be performed for a deep- diagnosed acute lymphoblastic leukemia (1985-2000).
er analysis and more cases need to be prospectively followed-up, Leukemia. 2010;24:320-34.
with constant monitoring, to gather more expressive data. 3. Steliarova-Foucher E, Colombet M, Ries LAG, Moreno F, Dolya
A, Bray F, et al. International incidence of childhood cancer,
2001–10: a population-based registry study. Lancet Oncol.
2017;18: 719-31.
Conclusions 4. Pui CH, Mullighan CG, Evans WE, Relling MV. Pediatric acute
lymphoblastic leukemia: where are we going and how do we
Taking into account the limitations of this case series, it can get there? Blood. 2012;120:1165-74.
be concluded that the buccal alterations and the presence of 5. Sociedade Brasileira de Oncologia Pediátrica. Protocolo
HSV-1, CMV and EBV in the evaluated ALL patients were inex- Brasileiro de tratamento da leucemia linfóide aguda na
pressive, with most of the patients presenting sound mucosa infância GBTLI LLA-2009. São Paulo: Campinas; 2011;1-347.
throughout the treatment, without occurrences of mucositis. 6. Brown CG, Wingard J. Clinical consequences of oral mucositis.
Semin Oncol Nurs. Semin Oncol Nurs. 2004;20:16-21.

It cannot be confirmed that the analyzed viruses integrate the 7. Toquica CPV, Silva PAM, Acero H. Caracterización clínico-
microbiome of those patients. However, there are indications epidemiológica de los pacientes pediátricos con leucemias
that the presence of EBV is more likely than HSV-1 and CMV, agudas en la Clínica Universitaria Colombia. Serie de casos
especially among child populations in developing countries, 2011-2014. Pediatr. 2016;49:17-22.
such as Brazil. 8. Ribeiro ILA, Limeira RRT, Castro RD, Bonan PRF, Valença AMG.
Oral Mucositis in Pediatric Patients in Treatment for Acute
Lymphoblastic Leukemia. Int J Environ Res Public Health.
2017;28;14:1468.
Acknowledgements 9. Aggarwal A, Pai KM. Orofacial Manifestations of Leukemic
Children on Treatment: A Descriptive Study. Int J Clin Pediatr
This study received financial support from the National Dent 2018;11:193-8.
Council for Scientific and Technological Development (CNPq/ 10. Mendonça RM, de Araújo M, Levy CE, Morari J, Silva RA, Yunes
Grant:486348/2013-0). The authors thank the Coordination for JA et al. Prospective evaluation of HSV, Candida spp., and
the Improvement of Higher Education Personnel (CAPES), the bucal bacteria on the severity of oral mucositis in pediatric
acute lymphoblastic leukemia. Support Care Cancer.
Ministry of Education of Brazil for the financial support to the 2012;20:1101-7.
Postgraduate Program in Dentistry at the Federal University 11. Chen YK, Hou HA, Chow JM, Chen YC, Hsueh PR, Tien HF. The
of Amazonas, the Molecular Diagnostic Laboratory and Mo- impact of oral herpes simplex virus infection and candidiasis
lecular Support Center of UFAM, the technical support from on chemotherapy-induced oral mucositis among patients
HEMOAM (Celia Maria Bolognese Ferreira and Cristina Motta with hematological malignancies. Eur J Clin Microbiol Infect
Ferreira), and the Foundation of Tropical Medicine (Dr. Luiz Dis. 2011;30:753-9.
Carlos de Lima Ferreira). We also thank Renata Gualberto da 12. Rüping MJ, Keulertz C, Vehreschild JJ, Lövenich H, Söhngen D,
Wieland U et al. Association of HSV reactivation and
Cunha for the technical collaboration. pro-inflammatory cytokine levels with the severity of
stomatitis after BEAM chemotherapy and autologous SCT.
Support Care Cancer. 2011;19:1211-6.
Ethical disclosures 13. Halenius A, Hengel H. Human cytomegalovirus and
Protection of human and animal subjects. The authors autoimmune disease. Biomed Res Int. 2014;1-15.
declare that the procedures followed were in accordance with 14. Chen CY, Huang KY, Shen JH, Tsao KC, Huang YC. A large-
scale seroprevalence of epstein-barr virus in Taiwan. Plos
the regulations of the relevant clinical research ethics com- One. 2015;10:1-11.
mittee and with those of the Code of Ethics of the World Med- 15. Salina TD, Ferreira YA, Alves EB, Ferreira CM, De Paula EV,
ical Association (Declaration of Helsinki). Mira MT et al. Role of peripheral blood minimum residual
disease at day 8 of induction therapy in high-riskpediatric
Confidentiality of data. The authors declare that they have
patients with acute lymphocytic leukemia. Sci Rep. 2016;
followed the protocols of their work center on the publication 6:31179.
of patient data. 16. World Health Organization, 1979. Handbook for Reporting
Results of Cancer Treatment. World Health Organization,
Right to privacy and informed consent. The authors have Switzerland: Geneva, 1979. E-book available on <https://apps.
obtained the written informed consent of the patients or sub- who.int/iris/handle/10665/37200> Access in June/2019.
jects mentioned in the article. The corresponding author is in 17. Otmani N, Alami R, Hessissen L, Mokhtari A, Soulaymani A,
possession of this document. Khattab M. Determinants of severe oral mucositis in